EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Free Fetal Haemoglobin in Severe Early‐Onset Fetal Growth Restriction: A Prospective Multi‐Centre Study

Adam Brook, Georgia Baynes iD, Jonathan Scargill, Angelos Evangelinos, Charlotte Brennan-Richardson, Freya Dow, Yuval Ginsberg, Tal Weissbach iD, Jana Brodszki, Eva Hansson, Anke Diemert, Kurt Hecher und 6 weitere

BJOG: An International Journal of Obstetrics & Gynaecology · 2026

DOI: 10.1111/1471-0528.18104 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, 2026. Verfasst von Adam Brook und 17 weiteren Autor:innen. Beteiligte Einrichtung: Maternal and Fetal Health Research Centre, University of Manchester, Manchester, UK. Hauptthemen laut MEDLINE: Fetal Growth Retardation, Fetal Hemoglobin, Fetal Blood. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellbeing of Women, Seventh Framework Programme, Regional Skane Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess fetal circulating free fetal haemoglobin (fHbF) levels and heme defences, correlated to fetal circulatory biometry and fetal sex in severe early‐onset fetal growth restriction (FGR). Design, Setting and Population A prospective study severe early‐onset fetal growth restriction pregnancies with close clinical management (estimated fetal weight (EFW) < 3rd centile and < 600 g at 20–26 + 6 weeks; N = 20). Method & Main Outcome Measures Temporal fetal vascular obstetric biometry was recorded. Cord blood fHbF and key heme‐scavenger defences were measured and compared with normal term births ( N = 26) and births with late‐onset FGR ( N = 12). Results fHbF was elevated in early‐onset FGR compared with normal pregnancy: 0.437(0.337/0.753) mg/mL; and 0.098 (0.045/0.264) mg/mL, respectively ( p < 0.0001); whilst hemopexin was downregulated in early‐ ( p < 0.001) and late‐onset FGR ( p < 0.0001), compared to normal pregnancy: 36(14/81) μg/mL, 25(19/40) μg/mL, and 155(132/219) μg/mL, respectively; median (interquartile ranges). Early‐onset FGR male fetuses had higher HbF compared with the normal males: 0.710(0.433/0.857) mg/mL; ( p < 0.001); 0.099(0.043/0.246) mg/mL, respectively; median (interquartile ranges). In early‐onset FGR, ratios of mid‐cerebral artery and umbilical artery pulsatility indices correlated positively with heme‐scavenger levels (hemopexin and a heme‐handling composite measure: p < 0.05, r = 0.672; and p < 0.01, r = 0.620; respectively), indicating lower levels are associated with cerebral vascular redistribution. These heme handling measures also positively correlated with gestational age at delivery ( r = 0.713 and r = 0.642, respectively, p < 0.01, both) and birthweight ( r = 0.742, p < 0.001; and r = 0.523, p < 0.05; respectively).

Conclusion

Overproduction of fHbF and an inadequate heme defence may contribute to fetal distress and poor umbilical arterial Dopplers in early onset FGR due to elevated placental vascular resistance and vascular inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fetal Growth RetardationFetal HemoglobinFetal BloodHumansFemalePregnancyProspective StudiesMaleAdultUmbilical ArteriesGestational AgeInfant, NewbornFetal WeightHemopexinUltrasonography, Prenatal

Stichwörter der Autor:innen

alpha 1 microglobulinfetal growth restrictionhaemoglobinhemopexin

Substanzen

Fetal HemoglobinHemopexin

Autor:innen und Institutionen

  • Maternal and Fetal Health Research Centre, University of Manchester, Manchester, UK.
  • Manchester Academic Health Sciences Centre, Manchester, UK.
  • Northern Care Alliance NHS Group, Royal Oldham Hospital, Manchester, UK.
  • Department of Obstetrics and Gynecology, Rambam Medical Centre, Haifa, Israel.
  • Department of Obstetrics and Gynecology, Sheba Medical Center, Tel Aviv, Israel.
  • Department of Obstetrics and Gynecology, Institute of Clinical Sciences Lund, Lund University and Skåne University Hospital, Malmö, Sweden.

ORCID-Profile: Georgia Baynes, Tal Weissbach, Neil Marlow, Anna L David, Paul Brownbill

Förderung

  • Wellbeing of Women
  • Seventh Framework Programme
  • Regional Skane Foundation
  • Swedish Research Council
  • Vetenskapsrådet

Zitieren

APA

Brook, A., Baynes, G., Scargill, J., Evangelinos, A., Brennan-Richardson, C., Dow, F., Ginsberg, Y., Weissbach, T., Brodszki, J., Hansson, E., Diemert, A., Hecher, K., Maksym, K., Marlow, N., Spencer, R. N., David, A. L., Hansson, S. R., & Brownbill, P. (2026). Free Fetal Haemoglobin in Severe Early‐Onset Fetal Growth Restriction: A Prospective Multi‐Centre Study. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.18104

Vancouver

Brook A, Baynes G, Scargill J, Evangelinos A, Brennan-Richardson C, Dow F, et al. Free Fetal Haemoglobin in Severe Early‐Onset Fetal Growth Restriction: A Prospective Multi‐Centre Study. BJOG: An International Journal of Obstetrics & Gynaecology. 2026. doi:10.1111/1471-0528.18104

BibTeX
@article{Brook2026,
  author = {Brook, Adam and Baynes, Georgia and Scargill, Jonathan and Evangelinos, Angelos and Brennan-Richardson, Charlotte and Dow, Freya and Ginsberg, Yuval and Weissbach, Tal and Brodszki, Jana and Hansson, Eva and Diemert, Anke and Hecher, Kurt and Maksym, Katarzyna and Marlow, Neil and Spencer, Rebecca N and David, Anna L and Hansson, Stefan R and Brownbill, Paul},
  title = {Free Fetal Haemoglobin in Severe Early‐Onset Fetal Growth Restriction: A Prospective Multi‐Centre Study},
  journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
  year = {2026},
  doi = {10.1111/1471-0528.18104}
}
Kostenlos starten →